EP2078071 - RATIONALLY DESIGNED MEDIA FOR CELL CULTURE [Right-click to bookmark this link] | Status | Patent revoked Status updated on 25.03.2022 Database last updated on 17.08.2024 | |
Former | The patent has been granted Status updated on 07.11.2017 | Most recent event Tooltip | 25.03.2022 | Revocation of patent | published on 27.04.2022 [2022/17] | Applicant(s) | For all designated states Wyeth LLC 235 East 42nd Street New York, NY 10017-5755 / US | [2014/10] |
Former [2010/16] | For all designated states Wyeth LLC Five Giralda Farms Madison, NJ 07940 / US | ||
Former [2009/29] | For all designated states Wyeth 5 Giralda Farms Madison, NJ 07940 / US | Inventor(s) | 01 /
LUAN, Yen-Tung 3 Armand Drive Chelmsford, MA 01824 / US | 02 /
WANG, Wenge 1 Hollow Ridge Road North Chelmsford, MA 01863 / US | 03 /
NOLAN, Ryan 71 Montvale Avenue, Apt.5 Stoneham, MA 02180 / US | 04 /
DRAPEAU, Denis 55 Old Farm Road Salem, NH 03079 / US | [2009/29] | Representative(s) | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstraße 4 22607 Hamburg / DE | [N/P] |
Former [2012/33] | Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR | ||
Former [2010/29] | Pringot, Thomas, et al Pfizer Limited European Patent Department Ramsgate Road Sandwich, Kent CT13 9NJ / GB | ||
Former [2009/29] | Denholm, Anna Marie, et al Wyeth Pharmaceuticals Huntercombe Lane South Taplow Maidenhead Berkshire SL6 0PH / GB | Application number, filing date | 07868688.8 | 07.11.2007 | [2009/29] | WO2007US83947 | Priority number, date | US20060858289P | 08.11.2006 Original published format: US 858289 P | [2009/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008063892 | Date: | 29.05.2008 | Language: | EN | [2008/22] | Type: | A2 Application without search report | No.: | EP2078071 | Date: | 15.07.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.05.2008 takes the place of the publication of the European patent application. | [2009/29] | Type: | B1 Patent specification | No.: | EP2078071 | Date: | 18.03.2015 | Language: | EN | [2015/12] | Search report(s) | International search report - published on: | EP | 28.08.2008 | Classification | IPC: | C12Q1/02, C12N5/00 | [2014/42] | CPC: |
A61P43/00 (EP);
C12P21/00 (KR);
C12Q1/02 (US);
C12N5/00 (KR);
C12N5/0018 (EP,US);
C12N2500/32 (EP,US)
|
Former IPC [2009/29] | C12N5/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/29] | Title | German: | RATIONAL ENTWORFENE MEDIEN FÜR ZELLKULTUR | [2009/29] | English: | RATIONALLY DESIGNED MEDIA FOR CELL CULTURE | [2009/29] | French: | MILIEUX CONÇUS RATIONNELLEMENT POUR UNE CULTURE CELLULAIRE | [2009/29] | Entry into regional phase | 08.05.2009 | National basic fee paid | 08.05.2009 | Designation fee(s) paid | 08.05.2009 | Examination fee paid | Examination procedure | 08.05.2009 | Examination requested [2009/29] | 23.09.2009 | Despatch of a communication from the examining division (Time limit: M06) | 09.07.2010 | Reply to a communication from the examining division | 06.02.2012 | Despatch of a communication from the examining division (Time limit: M06) | 25.09.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 19.11.2012 | Reply to a communication from the examining division | 17.03.2014 | Despatch of a communication from the examining division (Time limit: M06) | 01.09.2014 | Reply to a communication from the examining division | 13.10.2014 | Communication of intention to grant the patent | 04.02.2015 | Fee for grant paid | 04.02.2015 | Fee for publishing/printing paid | 04.02.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | EP15159383.7 / EP2921552 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.09.2009 | Opposition(s) | Opponent(s) | 01
17.12.2015
ADMISSIBLE F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB, et al, et al Siebertstrasse 3 81675 München / DE | 02
17.12.2015
ADMISSIBLE Spencer, Matthew Peter Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road London WC1X 8BT / GB Opponent's representative Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | [N/P] |
Former [2016/03] | |||
Opponent(s) | 01
17.12.2015
ADMISSIBLE F.Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB, et al, et al Siebertstrasse 3 81675 München / DE | ||
02
17.12.2015
ADMISSIBLE Spencer, Matthew Peter Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road London WC1X 8BT / GB Opponent's representative Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road London WC1X 8BT / GB | 03.02.2016 | Invitation to proprietor to file observations on the notice of opposition | 16.08.2016 | Reply of patent proprietor to notice(s) of opposition | 06.10.2017 | Date of oral proceedings | 08.11.2017 | Despatch of minutes of oral proceedings | 08.11.2017 | Despatch of communication that the patent will be revoked | 17.03.2022 | Legal effect of revocation of patent [2022/17] | Appeal following opposition | 09.01.2018 | Appeal received No. T0079/18 | 19.03.2018 | Statement of grounds filed | 17.03.2022 | Result of appeal procedure: appeal of the proprietor withdrawn | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 19.11.2012 | Request for further processing filed | 19.11.2012 | Full payment received (date of receipt of payment) Request granted | 29.11.2012 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 09.07.2010 | Request for further processing filed | 09.07.2010 | Full payment received (date of receipt of payment) Request granted | 23.07.2010 | Decision despatched | Fees paid | Renewal fee | 06.11.2009 | Renewal fee patent year 03 | 30.11.2010 | Renewal fee patent year 04 | 30.11.2011 | Renewal fee patent year 05 | 30.11.2012 | Renewal fee patent year 06 | 02.12.2013 | Renewal fee patent year 07 | 01.12.2014 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 18.03.2015 | EE | 18.03.2015 | LT | 18.03.2015 | LV | 18.03.2015 | MC | 18.03.2015 | MT | 18.03.2015 | IS | 18.07.2015 | [2017/40] |
Former [2016/28] | EE | 18.03.2015 | |
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
MC | 18.03.2015 | ||
IS | 18.07.2015 | ||
Former [2015/51] | EE | 18.03.2015 | |
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
IS | 18.07.2015 | ||
Former [2015/49] | EE | 18.03.2015 | |
LT | 18.03.2015 | ||
LV | 18.03.2015 | ||
Former [2015/39] | LT | 18.03.2015 | |
LV | 18.03.2015 | ||
Former [2015/35] | LT | 18.03.2015 | Cited in | International search | [X]US5122469 (MATHER JENNIE P [US], et al) [X] 1-45 * "Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins" * * abstract * * column 2, line 48 - line 68 * * column 4, line 52 - column 7, line 44 * * tables 1-4 *; | [DX]US2006121568 (DRAPEAU DENIS [US], et al) [DX] 1-45 * "Production of polypeptides" * * page 1, paragraph 5 * * page 10, paragraph 151 * * tables 1,11 * * page 31 - page 32; example 13; table 22 *; | [XA] - CASTRO P M L ET AL, "Application of a statistical design to the optimization of culture medium for recombinant interferon-gamma production by Chinese hamster ovary cells", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER VERLAG, BERLIN, DE, (19920101), vol. 38, no. 1, ISSN 0175-7598, pages 84 - 90, XP002995069 [X] 1,28,30,32,33 * the whole document * [A] 2-27,29,31,34-45 DOI: http://dx.doi.org/10.1007/BF00169424 | [XA] - SANDADI SANDEEPA ET AL, "Heuristic optimization of antibody production by Chinese hamster ovary cells.", BIOTECHNOLOGY PROGRESS 2005 SEP-OCT, (200509), vol. 21, no. 5, ISSN 8756-7938, pages 1537 - 1542, XP002484344 [X] 1,28,30,32,33 * the whole document * [A] 2-27,29,31,34-45 DOI: http://dx.doi.org/10.1021/bp0501266 | Opposition | GB2251249 | WO9512664 | EP1229125 | WO2006026408 | US2006121568 | EP1686173 | WO2006099308 | US4282326 | US2005272124 | WO2006026445 | WO2006084826 | WO2008063892 | - LING et al., "CHEMICALLY CHARACTERIZED CONCENTRATED CORODIES FOR CONTINOUS CELL CULTURE (THE 7C'S CULTRURE MEDIA)", Experimental Cell Research, (19680000), vol. 52, pages 469 - 489, XP000990215 DOI: http://dx.doi.org/10.1016/0014-4827(68)90489-8 | - DEMAIN et al., "Effective levels of tetanus toxin can be made in a production medium totally lacking both animal (e.g., brain heart infusion) and dairy proteins or digests (e.g., casein hydrolysates)", Vaccine, (20050502), vol. 23, pages 5420 - 5423, XP005158050 DOI: http://dx.doi.org/10.1016/j.vaccine.2005.03.043 | - "QUEST INTERNATIONAL PRODUCT INFORMATION", (19980000), URL: http://www.sheffield-products.com , XP002156903 | - CHEN et al., "Effects of amino acid additions on ammonium stressed CHO cells", Journal of Biotechnology, (20050525), vol. 117, no. 3, pages 277 - 286, XP004872691 DOI: http://dx.doi.org/10.1016/j.jbiotec.2005.02.003 | - LING et al., "Chemically characterized concentrated corodies for continuous cell culture (The 7C's culture media)", Experimental Cell Research, (19680000), vol. 52, pages 469 - 489, XP024792176 DOI: http://dx.doi.org/10.1016/0014-4827(68)90489-8 | - MORGAN, J.F. et al., "Nutrition of Animal Cells in Tissue Culture. I. Initial Studies on a Synthetic Medium (17557)", Proceedings of the Society for Experimental Biology and Medicine, (19500100), vol. 73, no. 1, pages 1 - 8, XP055254255 | - WLASCHIN et al., "Fedbatch culture and dynamic nutrient feeding", Adv. Biochem Engin/Biotechnol, (20060610), vol. 101, pages 43 - 74, XP009092044 | - BUTLER, "Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals", Appl Microbiol Biotechnol, (20050416), vol. 68, pages 283 - 291, XP002457678 DOI: http://dx.doi.org/10.1007/s00253-005-1980-8 | - BIRCH et al., "Antibody production", Advanced Drug Delivery Reviews, (20060522), vol. 58, pages 671 - 685, XP005611421 DOI: http://dx.doi.org/10.1016/j.addr.2005.12.006 | - JAYAPAL et al., "Recombinant Protein Therapeutics from CHO Cells -- 20 Years and Counting", CHO consortium, SBE Special Section, (20071000), pages 40 - 47, XP055254248 | - Sigma Aldrich, "Medium 199, with Earle′s salts, L-glutamine and sodium bicarbonate, liquid, sterile-filtered, suitable for cell cultur", Technical information, pages 1 - 4 |